the 30th Anniversary of Mizutani Foundation for Glycoscience
43/154

43Jamey D. MarthEnvironmental and pathogenic triggers of intestinal inflammatory diseaseTadashi SuzukiClarification of a novel degradation pathway for O-Man glycans in S. cerevisiaeYoshio HirabayashiGlycolipids generated by metabolic crosstalk between sphingolipid and sterolAnant K. MenonMolecular mechanism of glucosylation of the dolichol-linked N-glycan precursorKohji ItohDevelopment of neoglycobiologics using transglycosylation technologyYu YamaguchiThe novel cell surface hyaluronidase TMEM2 in tumor cell invasionYoshiko MurakamiA novel structure of GPI anchored proteins and its physiological roleMohamed Abdel-MohsenReversal of HIV latency by Galectin-9 in vivoSeth B. HerzonDevelopment of an umpolung glycosylation for the synthesis of α- or β-linked O-2-deoxyglycosidesFrances PlattGanglioside biosynthetic diseasesKatsunori TanakaTherapeutic in vivo synthetic chemistry by glycosylated artificial metalloenzymeYoshiki NarimatsuDisplay of the Human Mucinome with Defined O-Glycans by Gene Engineered Cells– Potential for mucin therapeuticsKenji UchimuraRegulation of amyloid clearance by heparan sulfate remodelingTakeshi TakahashiImproved human xenograft in NOG mice by manipulating receptors for glycansGo HiraiDevelopment of novel mechanism-based inhibitors for glycohydrolases201920202021

元のページ  ../index.html#43

このブックを見る